74 related articles for article (PubMed ID: 25342326)
1. MicroRNA library-based functional screening identified miR-137 as a suppresser of gastric cancer cell proliferation.
Zheng X; Dong J; Gong T; Zhang Z; Wang Y; Li Y; Shang Y; Li K; Ren G; Feng B; Li J; Tian Q; Tang S; Sun L; Li M; Zhang H; Fan D
J Cancer Res Clin Oncol; 2015 May; 141(5):785-95. PubMed ID: 25342326
[TBL] [Abstract][Full Text] [Related]
2. microRNA-3129 promotes cell proliferation in gastric cancer cell line SGC7901 via positive regulation of pRb.
Yang S; Sheng N; Pan L; Cao J; Liu J; Ma R
Braz J Med Biol Res; 2018; 51(6):e6452. PubMed ID: 29791595
[TBL] [Abstract][Full Text] [Related]
3. MiRNA-12129 Suppresses Cell Proliferation and Block Cell Cycle Progression by Targeting SIRT1 in GASTRIC Cancer.
Zhang W; Liao K; Liu D
Technol Cancer Res Treat; 2020; 19():1533033820928144. PubMed ID: 32508267
[TBL] [Abstract][Full Text] [Related]
4. miR-199a and miR-199b facilitate diffuse gastric cancer progression by targeting Frizzled-6.
Hong SA; Lee S; Park J; Hong M; Yoon JS; Lee H; Lee JH; Kim S; Won HS; Kang K; Ko YH; Ahn YH
Sci Rep; 2023 Oct; 13(1):17480. PubMed ID: 37838767
[TBL] [Abstract][Full Text] [Related]
5. miR-1304 targets KLK11 to regulate gastric cancer cell proliferation through the mTOR signaling pathway.
Ding Y; Wang Z; Chen C; Li D; Wang W; Jia Y; Qin Y
Carcinogenesis; 2024 Feb; 45(1-2):45-56. PubMed ID: 37971062
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of microRNA-21 on differentially expressed hub genes in gastric cancer based on systems biology.
Kalajahi HG; Yari A; Amini M; Catal T; Ahmadpour Youshanlui M; Pourbagherian O; Zhmurov CS; Mokhtarzadeh A
Sci Rep; 2023 Dec; 13(1):21906. PubMed ID: 38081950
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs are involved in the development and progression of gastric cancer.
Liu X; Ma R; Yi B; Riker AI; Xi Y
Acta Pharmacol Sin; 2021 Jul; 42(7):1018-1026. PubMed ID: 33037405
[TBL] [Abstract][Full Text] [Related]
8. miR-203 suppression in gastric carcinoma promotes Slug-mediated cancer metastasis.
Shi Y; Tan YJ; Zeng DZ; Qian F; Yu PW
Tumour Biol; 2015 Jul; ():. PubMed ID: 26194864
[TBL] [Abstract][Full Text] [Related]
9. MiR-33 connects cholesterol to the cell cycle.
Inukai S; Slack FJ
Cell Cycle; 2012 Mar; 11(6):1060-1. PubMed ID: 22391211
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA dysregulation as a prognostic biomarker in colorectal cancer.
Dong Y; Yu J; Ng SS
Cancer Manag Res; 2014; 6():405-22. PubMed ID: 25342918
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of microRNA 502 binding site SNP in the 3'-untranslated region of the SET8 gene in patients with non-Hodgkin's lymphoma.
Diao L; Su H; Wei G; Li T; Gao Y; Zhao G; Guo Z
Tumori; 2014; 100(5):553-8. PubMed ID: 25343552
[TBL] [Abstract][Full Text] [Related]
12. Primary analysis and screening of microRNAs in gastric cancer side population cells.
Zhang HH; Gu GL; Zhang XY; Li FZ; Ding L; Fan Q; Wu R; Shi W; Wang XY; Chen L; Wei XM; Yuan XY
World J Gastroenterol; 2015 Mar; 21(12):3519-26. PubMed ID: 25834316
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of miR-137 is a frequent event in gastric carcinogenesis.
Steponaitiene R; Kupcinskas J; Langner C; Balaguer F; Venclauskas L; Pauzas H; Tamelis A; Skieceviciene J; Kupcinskas L; Malfertheiner P; Link A
Mol Carcinog; 2016 Apr; 55(4):376-86. PubMed ID: 25663388
[TBL] [Abstract][Full Text] [Related]
14. TargetCompare: A web interface to compare simultaneous miRNAs targets.
Moreira FC; Dustan B; Hamoy IG; Ribeiro-Dos-Santos AM; Dos Santos AR
Bioinformation; 2014; 10(9):602-5. PubMed ID: 25352731
[TBL] [Abstract][Full Text] [Related]
15. miR‑137 is a diagnostic tumor‑suppressive miRNA that targets SPHK2 to promote M1‑type tumor‑associated macrophage polarization.
Liu J; Xu Y; Tang H; Liu X; Sun Y; Wu T; Gao M; Chen P; Hong H; Huang G; Zhou Y
Exp Ther Med; 2023 Aug; 26(2):397. PubMed ID: 37533491
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma.
Luo SS; Liao XW; Zhu XD
J Cancer; 2019; 10(25):6298-6313. PubMed ID: 31772663
[No Abstract] [Full Text] [Related]
17. MicroRNA-126 affects ovarian cancer cell differentiation and invasion by modulating expression of vascular endothelial growth factor.
Luo J; Zhu C; Wang H; Yu L; Zhou J
Oncol Lett; 2018 Apr; 15(4):5803-5808. PubMed ID: 29552211
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of microRNAs in gastric cancer: a meta-analysis.
Zhang Y; Guan DH; Bi RX; Xie J; Yang CH; Jiang YH
Oncotarget; 2017 Aug; 8(33):55489-55510. PubMed ID: 28903436
[TBL] [Abstract][Full Text] [Related]
19. Combining multi-dimensional data to identify key genes and pathways in gastric cancer.
Ren W; Li W; Wang D; Hu S; Suo J; Ying X
PeerJ; 2017; 5():e3385. PubMed ID: 28603669
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of miR-137 contributes to early colorectal carcinogenesis by impaired Aurora-A inhibition.
Huang YC; Lee CT; Lee JC; Liu YW; Chen YJ; Tseng JT; Kang JW; Sheu BS; Lin BW; Hung LY
Oncotarget; 2016 Nov; 7(47):76852-76866. PubMed ID: 27764771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
